Insudiab is 90 capsules containing Soodium Butyrate in microgranules – the best available form of Sodium Butyrate, which is an effective pharmacological approach for type 2 diabetes and insulin resistance.
Butyrate-mediated GLP-1 (intestinal hormone) secretion has been considered to be a major factor in the improvement of insulin sensitivity and decrease hepatic gluconeogenesis. It plays an important role in glucose homeostasis which makes this hormone an ideal candidate for the treatment of type 2 diabetes, insulin resistance, weight loss and cholesterol level reduction.
The preparation can be used in all age groups without significant contraindications. Numerous studies from PubMed database have shown that sodium butyrate is effective without significant side effects.